Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance

Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.74, $0.01 better than the analyst estimate of $0.73. Revenue for the quarter came in at $708.4 million versus the consensus estimate of $680.1 million.

GUIDANCE:

Bruker sees FY2023 EPS of $2.52-$2.57, versus the consensus of $2.57. Bruker sees FY2023 revenue of $2.81-2.86 billion, versus the consensus of $2.61 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c